Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2026-04-17 @ 11:05 AM
Study NCT ID:
NCT05363592
Status:
COMPLETED
Last Update Posted:
2023-01-12
First Post:
2022-04-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers
Sponsor:
Celltrion
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CT-L01-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None